
Layla Soroush
Examiner (ID: 5579, Phone: (571)272-5008 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1617, 1627, 1622 |
| Total Applications | 1224 |
| Issued Applications | 397 |
| Pending Applications | 162 |
| Abandoned Applications | 696 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8211643
[patent_doc_number] => 20120129937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'SOLUBILIZER FOR COSMETIC PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/300104
[patent_app_country] => US
[patent_app_date] => 2011-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13650
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129937.pdf
[firstpage_image] =>[orig_patent_app_number] => 13300104
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/300104 | SOLUBILIZER FOR COSMETIC PREPARATIONS | Nov 17, 2011 | Abandoned |
Array
(
[id] => 9370922
[patent_doc_number] => 20140080795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'NRF2 Deficiency Influences Susceptibility to Steroid Resistance via HDAC2 Reduction'
[patent_app_type] => utility
[patent_app_number] => 13/988038
[patent_app_country] => US
[patent_app_date] => 2011-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13953
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988038
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/988038 | NRF2 Deficiency Influences Susceptibility to Steroid Resistance via HDAC2 Reduction | Nov 17, 2011 | Abandoned |
Array
(
[id] => 8199409
[patent_doc_number] => 20120122872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Treatment or Prevention of Fungal Infections with PDK1 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/298766
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7318
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122872.pdf
[firstpage_image] =>[orig_patent_app_number] => 13298766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/298766 | Treatment or prevention of fungal infections with PDK1 inhibitors | Nov 16, 2011 | Issued |
Array
(
[id] => 8458119
[patent_doc_number] => 08293787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-23
[patent_title] => 'Gallium compositions for the treatment of liver cancer and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/282740
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3813
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13282740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282740 | Gallium compositions for the treatment of liver cancer and methods of use | Oct 26, 2011 | Issued |
Array
(
[id] => 15051119
[patent_doc_number] => 10455832
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-10-29
[patent_title] => Compositions and methods of product application to target and kill all life stages of bed bugs
[patent_app_type] => utility
[patent_app_number] => 13/278024
[patent_app_country] => US
[patent_app_date] => 2011-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3363
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13278024
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/278024 | Compositions and methods of product application to target and kill all life stages of bed bugs | Oct 19, 2011 | Issued |
Array
(
[id] => 8126665
[patent_doc_number] => 20120087877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'COMPOSITION BASED ON MINERAL CONCENTRATES DERIVED FROM PRECIOUS STONES'
[patent_app_type] => utility
[patent_app_number] => 13/273646
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5544
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20120087877.pdf
[firstpage_image] =>[orig_patent_app_number] => 13273646
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273646 | COMPOSITION BASED ON MINERAL CONCENTRATES DERIVED FROM PRECIOUS STONES | Oct 13, 2011 | Abandoned |
Array
(
[id] => 8253100
[patent_doc_number] => 20120157423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/317113
[patent_app_country] => US
[patent_app_date] => 2011-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5972
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157423.pdf
[firstpage_image] =>[orig_patent_app_number] => 13317113
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/317113 | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof | Oct 10, 2011 | Issued |
Array
(
[id] => 8035221
[patent_doc_number] => 20120067343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'Aerosol Composition for Administering Drugs'
[patent_app_type] => utility
[patent_app_number] => 13/237725
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4051
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20120067343.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237725
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237725 | Aerosol Composition for Administering Drugs | Sep 19, 2011 | Abandoned |
Array
(
[id] => 8043635
[patent_doc_number] => 20120071557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'ANIMAL FEED COMPOSITIONS OF ABSCISIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/236472
[patent_app_country] => US
[patent_app_date] => 2011-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5992
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071557.pdf
[firstpage_image] =>[orig_patent_app_number] => 13236472
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/236472 | ANIMAL FEED COMPOSITIONS OF ABSCISIC ACID | Sep 18, 2011 | Abandoned |
Array
(
[id] => 9162145
[patent_doc_number] => 20130310422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'REVERSAL OF GENERAL ANESTHESIA BY ADMINISTRATION OF METHYLPHENIDATE, AMPHETAMINE, MODAFINIL, AMANTADINE, AND/OR CAFFEINE'
[patent_app_type] => utility
[patent_app_number] => 13/819924
[patent_app_country] => US
[patent_app_date] => 2011-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 30520
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819924
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/819924 | REVERSAL OF GENERAL ANESTHESIA BY ADMINISTRATION OF METHYLPHENIDATE, AMPHETAMINE, MODAFINIL, AMANTADINE, AND/OR CAFFEINE | Aug 31, 2011 | Abandoned |
Array
(
[id] => 8701633
[patent_doc_number] => 08394855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => 'Cosmetic compositions'
[patent_app_type] => utility
[patent_app_number] => 13/137659
[patent_app_country] => US
[patent_app_date] => 2011-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8012
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13137659
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/137659 | Cosmetic compositions | Aug 31, 2011 | Issued |
Array
(
[id] => 8629987
[patent_doc_number] => 08362059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Anti-fungal formulation'
[patent_app_type] => utility
[patent_app_number] => 13/214130
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 39098
[patent_no_of_claims] => 134
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13214130
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/214130 | Anti-fungal formulation | Aug 18, 2011 | Issued |
Array
(
[id] => 8429738
[patent_doc_number] => 20120251613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'METHOD FOR TREATING VITILIGO WITH A PROSTAGLANDIN ANALOGUE'
[patent_app_type] => utility
[patent_app_number] => 13/194458
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8383
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13194458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/194458 | METHOD FOR TREATING VITILIGO WITH A PROSTAGLANDIN ANALOGUE | Jul 28, 2011 | Abandoned |
Array
(
[id] => 7733728
[patent_doc_number] => 20120016021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'METHODS OF TREATING FRAGILE X SYNDROME, DOWN\'S SYNDROME, AUTISM AND RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/184070
[patent_app_country] => US
[patent_app_date] => 2011-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18244
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20120016021.pdf
[firstpage_image] =>[orig_patent_app_number] => 13184070
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/184070 | METHODS OF TREATING FRAGILE X SYNDROME, DOWN'S SYNDROME, AUTISM AND RELATED DISORDERS | Jul 14, 2011 | Abandoned |
Array
(
[id] => 8866635
[patent_doc_number] => 20130150338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'ANTI-DANDRUFF SHAMPOO'
[patent_app_type] => utility
[patent_app_number] => 13/816265
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5459
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816265
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/816265 | Anti-dandruff shampoo | Jul 13, 2011 | Issued |
Array
(
[id] => 7733411
[patent_doc_number] => 20120015915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D'
[patent_app_type] => utility
[patent_app_number] => 13/182251
[patent_app_country] => US
[patent_app_date] => 2011-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4500
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015915.pdf
[firstpage_image] =>[orig_patent_app_number] => 13182251
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/182251 | FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D | Jul 12, 2011 | Abandoned |
Array
(
[id] => 7502044
[patent_doc_number] => 20110263710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'Transepithelial methods of using gamma aminobutyric acid compositions for pain relief'
[patent_app_type] => utility
[patent_app_number] => 13/067827
[patent_app_country] => US
[patent_app_date] => 2011-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5324
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263710.pdf
[firstpage_image] =>[orig_patent_app_number] => 13067827
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/067827 | Transepithelial methods of using gamma aminobutyric acid compositions for pain relief | Jun 28, 2011 | Abandoned |
Array
(
[id] => 8951247
[patent_doc_number] => 20130197028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'nAChRalpha7 Agonists and nAChRalpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn\'s Disease (CD)'
[patent_app_type] => utility
[patent_app_number] => 13/805811
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13238
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805811
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/805811 | nAChRalpha7 Agonists and nAChRalpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD) | Jun 23, 2011 | Abandoned |
Array
(
[id] => 7669014
[patent_doc_number] => 20110318283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'USE OF ANTIBACTERIAL COMPOUNDS FOR THE ORAL CAVITY HYGIENE'
[patent_app_type] => utility
[patent_app_number] => 13/162355
[patent_app_country] => US
[patent_app_date] => 2011-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4517
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162355
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/162355 | USE OF ANTIBACTERIAL COMPOUNDS FOR THE ORAL CAVITY HYGIENE | Jun 15, 2011 | Abandoned |
Array
(
[id] => 7663777
[patent_doc_number] => 20110313046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'COMBINATION THERAPY WITH LISDEXAMPHETAMINE AND EXTENDED RELEASE GUANFACINE'
[patent_app_type] => utility
[patent_app_number] => 13/157849
[patent_app_country] => US
[patent_app_date] => 2011-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9407
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20110313046.pdf
[firstpage_image] =>[orig_patent_app_number] => 13157849
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/157849 | COMBINATION THERAPY WITH LISDEXAMPHETAMINE AND EXTENDED RELEASE GUANFACINE | Jun 9, 2011 | Abandoned |